期刊文献+

MBD1甲基化调控胰腺癌BxPC-3细胞株mdr1转录及其表达的研究 被引量:4

MBD1 regulated expression and transcription of multidrug resistance 1 ( mdr1 ) by methylation in pancreatic cancer cell line BxPC-3
原文传递
导出
摘要 目的 观察MBD1通过对mdr1转录区域结合位点甲基化影响,在转录水平间接调控胰腺癌mdr1基因表达.方法 应用RNA干扰技术对人胰腺癌细胞株BxPC-3中MBD1基因进行抑制;应用定量荧光聚合酶链式反应(FQ-PCR)技术、MSP(甲基化专用聚合酶链式反应)方法分别检测转染前后细胞株中的mdr1 mRNA的表达差异和转录区域结合位点甲基化变化.结果 成功构建并转染MBDI siRNAs至人原位胰腺腺癌细胞BxPC-3(BxPC-3)细胞中,证实MBDI mRNA水平明显下调(下调幅度为93.19%).MBD1下调后,mdr1 DNA转录区域(-110GC和-50GC)甲基化分别上调(上调幅度分别为181.98%和409.57%);mdr1 mRNA表达明显下调(下调幅度为97.79%).结论 MBD1可通过对mdr1转录区域结合位点甲基化的影响,在转录水平间接调控胰腺癌mdr1基因表达. Objective To investigate that methyl-CpG binding domain protein 1 (MBD1) could regulate multidrug resistance gene 1 (mdr1) during its RNA transcription indirectly by influencing the methylation of mdr1 transcription domain. Methods MBD1 gene in human pancreatic cancer cell line BxPC-3 was depressed by RNA interference (RNAi). The expression of mdr1 mRNA and the methylation of its transcription domain were detected by the techniques of real-time fluorescent quantitative polymerase chain reaction (FQ-PCR) and methylations expression and metspecific PCR (MSP) respectively before and after transfection. Results MBD1 siRNAs were constructed and transfected into BxPC-3 successfully. The expression of MBD1 mRNA was down-regulated obviously (93. 19% ). The methylation of-1 10GC-box and-50GC-box was up-regulated (181. 98% and 409. 57% respectively) and the expression of mdr1 mRNA was down-regulated (97.79%) accordingly. Conclusion MBD1 could regulate the expression of mdr1 indirectly by influencing the methylation of mdr1 transcription domain during its RNA transcription.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第6期763-765,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30672057).
关键词 胰腺癌 多药耐药基因 转录 甲基化 Pancreatic carcinoma Multidrug resistant gene Transcription Methylation
  • 相关文献

参考文献15

  • 1王春友,赵刚.胰腺癌实验研究的现状与展望[J].中华实验外科杂志,2004,21(8):903-904. 被引量:9
  • 2Pirker R,Wallner J,Geissler K,et al.MDR1 gene expression and treatment outcome in acute myeloid leukemia.J Natl Cancer Inst,1991,83:708-712.
  • 3郭俊超,赵玉沛,廖泉,陈革,朱预.胰腺癌耐药细胞株SW1990/Fu产生获得性耐药机制的研究[J].中华实验外科杂志,2006,23(1):13-15. 被引量:2
  • 4Greenway BA.Carcinoma of the exocrine pancreas:a sex hormone responsive tumour? Br J Surg,1987,74:441-442.
  • 5Lu Z,Kleeff J,Shrikhande S,et al.Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer.Pancreas,2000,21:240-247.
  • 6陈旭,李建党,程长铭,王耀东,何协.P-糖蛋白与ER、PR在胰腺癌中的异常表达及临床意义[J].中国现代医学杂志,1999,9(7):20-21. 被引量:7
  • 7Schmutte C,Jones PA.Involvement of DNA methylation in human carcinogenesis.Biol Chem,1998,379:377-388.
  • 8Campanero MR,Armstrong MI,Flemington EK.CpG methylation as a mechanism for the regulation of E2F activity.Proc Natl Acad Sci USA,2000,97:6481-6486.
  • 9Ng HH,Jeppesen P,Bird A.Active repression of methylated genes by the chromosomal protein MBD1.Mol Cell Biol,2000,20:1394-1406.
  • 10Ahuja N,Li Q,Mohan AL,et al.Aging and DNA methylation in colorectal mucosa and cancer.Cancer Res,1998,58:5489-5494.

二级参考文献24

  • 1陈革,赵玉沛,郭俊超,张立阳,李丽君,吴元德.胰腺癌细胞株耐药与凋亡相关基因的改变[J].外科理论与实践,2004,9(4):325-328. 被引量:3
  • 2潘博,郭俊超,廖泉,赵玉沛.吉西他滨与胰腺癌化疗耐药[J].中国普外基础与临床杂志,2005,12(5):530-532. 被引量:16
  • 3郭俊超,赵玉沛,廖泉,陈革,张立阳.胰腺癌耐药细胞株SW1990/FU的建立、鉴定及生物学特性[J].中国医学科学院学报,2005,27(5):592-596. 被引量:15
  • 4Ng HH, Jeppesen P, Bird A. Active repression of methylated Genes by the chromosomal protein MBD1 [J].Molecular and Cellular Bio, 2000,20(4): 1394-1406.
  • 5Cross SH, Meehan RR, Nan X, et al. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat[J]. Genet, 1997,16(3):256-259.
  • 6Ballestar E, Wolffe AP. Methyl-CpG-bindinG proteins tarGetinG specific Gene repression [J]. Eur J Biochem,2001,268(1):1-6.
  • 7Gaubatz S, Lindeman GJ, Ishida S, et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control[J]. Mol Cell, 2000,6(3):729-735.
  • 8Esteller M, Corn PG, Baylin SB, et al. A Gene hypermethylation profile of human cancer[J]. Cancer Res, 2001,61 (8): 3225-3229.
  • 9Campanero MR, ArmstronG MI, FleminGton EK, et al.CpG methylation as a mechanism for the reGulation of E2F activity[J]. Proc Natl Acad Sci, 2000,97(12):6481-6486
  • 10Esteller M, Corn PG, Baylin SB, et al. A Gene hypermethylation profile of human cancer[J]. Cancer Res, 2001,61(8):3225-3229.

共引文献26

同被引文献32

  • 1Xian-Jun Yu,Jiang Long,De-Liang Fu,Qun-Hua Zhang,Quan-Xin Ni the Center for Pancreatic Cancer, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray[J].Hepatobiliary & Pancreatic Diseases International,2003,2(3):467-470. 被引量:8
  • 2张新晨,杨维良,徐华锋,吴德全,张伟峰,张东伟.葡萄糖调节蛋白78在胃癌组织中的表达及意义[J].中华实验外科杂志,2005,22(12):1483-1485. 被引量:16
  • 3郭文治,张水军,史翼华,郑守华.乙酰肝素酶2 mRNA和蛋白在胰腺癌中的表达及其意义[J].中华实验外科杂志,2007,24(8):942-944. 被引量:1
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statistics,2009. CA Cancer J Clin,2009, 59:225-249.
  • 5Cheng AM, gyrom MW, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvemest of miR- NA in cell growth and apoptosis. Nucleic Acids Res,2005,33 : 1290-1297.
  • 6Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet, 2009,10 : 704-714.
  • 7Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differ- entiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA ,2007,297:1901-1908.
  • 8Campomenosi P,Salis S,Lindqvist C,et al.Characterization of RNA-SET2,the first human member of the Rh/T2/S family of glycopro-teins.Arch Biochem Biophys,2006,449:17-26.
  • 9Deshpande RA,Shankar V.Ribonucleases from Tl family.Crit RevMicrobiol,2002,28:79-122.
  • 10Luhtala N,Parker R.T2 Family ribonucleases:ancient enzymes withdiverse roles.Trends Biochem Sci,2010,35:253-259.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部